Regen BioPharma (RGBP) Short Interest Ratio & Short Volume

Short interest is the volume of Regen BioPharma shares that have been sold short but have not yet been closed out or covered. As of January 15th, investors have sold 400 shares of RGBP short. Learn More on Regen BioPharma's current short interest.

Regen BioPharma saw a decrease in short interest in the month of January. As of January 15th, there was short interest totaling 400 shares, a decrease of 76.5% from the previous total of 1,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Regen BioPharma: American Bio Medica Co. (0.00%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.18 billion), Charter Communications, Inc. ($3.91 billion), Reddit, Inc. ($3.16 billion), The Kroger Co. ($2.75 billion), International Paper ($2.57 billion), Cencora, Inc. ($2.06 billion), SoFi Technologies, Inc. ($2.06 billion), Rivian Automotive, Inc. ($2.00 billion), Live Nation Entertainment, Inc. ($1.63 billion), and Hims & Hers Health, Inc. ($1.57 billion). View all of the most shorted stocks.

Short selling RGBP is an investing strategy that aims to generate trading profit from Regen BioPharma as its price is falling. RGBP shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Regen BioPharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RGBP, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RGBP, twice per month. The most recent reporting period available is January, 15 2025.